Citation: | YUAN Wenbo, DING Yongjuan, XU Jingjing. Determination of 5-fluorouracil in serum by direct protein precipitation-ultra performance liquid chromatography[J]. Journal of China Pharmaceutical University, 2015, 46(1): 81-84. DOI: 10.11665/j.issn.1000-5048.20150111 |
[1] |
Chu E.Clinical colorectal cancer:“ode to 5-fluorouracil”[J].Clin Colorectal Cancer,2007,6(9):609.
|
[2] |
Shitara K,Matsuo K,Mizota A,et al.Association of fluoropyrimidines,platinum agents,taxanes,and irinotecan in any line of chemotherapy with survival in patients with advanced gastric cancer[J].Gastric Cancer,2011,14(2):155-160.
|
[3] |
Leong T.Chemotherapy and radiotherapy in the management of gastric cancer[J].Curr Opin Gastroenterol,2005,21(6):673-678.
|
[4] |
Douillard JY,Cunningham D,Roth AD,et al.Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer:a multicentre randomized trial[J].Lancet,2000,3(55):1041-1047.
|
[5] |
Erick G,Remy D,Jacques J,et al.Individual fluorouracil dose adjustment based on pharmacokinetic follow-up compared with conventional dosage:results of a multicenter randomized trial of patients with metastatic colorectal cancer[J].J Clin Oncol,2008,26(28):2099-2105.
|
[6] |
Peng RJ,Dong QM,Shi YX,et al.Correlative analysis between serum dihydropyrimidine dehydrogenase activity,concentration of 5-fluorouracil and adverse events in the treatment of advanced gastric cancer patients[J].Chin J Cancer(癌症),2006,25(8):1039-1043.
|
[7] |
Cai X,Xue P,Song WF,et al.The role of pharmacokinetic monitoring of fluorouracil in improvement of efficacy and reduction of adverse reactions for patients with advanced gastric cancer[J].Tumor(肿瘤),2011,31(10):930-936.
|
[8] |
Yu JX,Cai J,Shi LM,et al.Determination of fluorouracil concentration in tissues by HPLC[J].Chin J Drug Appl Monit(中国药物应用与监测),2011,8(1):21-23.
|
[9] |
Anderson D,Blesing DJ,Blesing C,et al.Simultaneous gas chromatographic-mass spectrophotometric determination of α-fluoro-β-alanine and 5-fluorouracil in plasma[J].J Chromatogr B,1997,688(1):87-93.
|
[10] |
Milano G,Roman P,Khater R,et al.Dose versus pharmacokinetics for predicting tolerance to 5-day continuous infusion of 5-FU[J].Int J Cancer,1988,41(4):537-541.
|
[11] |
Zhang FH,Guzha NE,Shen W,et al.Determination of 5-fluorouracil in human plasma by HPLC[J].Gansu Med J(甘肃医药),2009,28(5):384-385.
|
[12] |
Guo ZL,Fan J.Comparison study of solid-phase extraction and protein precipitation for the determination of vancomycin in human serum by HPLC[J].Chin Hosp Pharm J(中国医院药学杂志),2013,33(9):745-747.
|
[13] |
Yuran C,Jing Z.Development and validation of a new UPLC method for vancomycin and comparison to FPIA(TDx)[C/OL]// The 11th National Academic Symposium of Chemotherapeutic Pharmacology.Guiyang,2012.[2014-10-9] .http://cpfd.cnki.com.cn/Article/CPFDTOTAL-ZGYS201207001014.htm
|
[14] |
Li HL,Qiao J,Cao M,et al.Comparison of six different precipitants for the determination of vancomycin and norvancomycin in human plasma[J].Shanxi Med J(山西医药杂志),2009,38(12):1154-1155.
|
[15] |
Jelena J,Hanna SS,Johan P,et al.Comparison of UPLC and HPLC for analysis of dietary folates[J].Chromatographia,2011,73(3/4):219-225.
|
[16] |
Asta O,Vilma O,Vida V,et al.UPLC a powerful tool for the separation of imidazolium ionic liquid cations[J].Chromatographia,2011,73(3/4):17-24.
|
[17] |
Quanyun AX,Reza K,Jay KT,et al.Quantitative determination of busulfan in human plasma by UPLC[J].Chromatographia,2009,70(9/10):1505-1510.
|